SUMMARY The molecular basis of activation and regulation of the phagocyte respiratory burst is discussed with particular reference to the role of inositol phospholipid hydrolysis, guanine nucleotide coupling proteins, and activation of protein kinase C.
Phagocytic cells-neutrophil and eosinophil polymorphs, and mononuclear phagocytes-possess a unique membrane bound flavoprotein/b-type cytochrome complex (NADPH-oxidase) which enables these cells, when activated, to generate large amounts of superoxide anion (07) at their surface. Oxy radical production by phagocytes is believed to have a direct role in their microbicidal and cytocidal activities' 2 and may also have a role in modulating the immune response.3 4 The inappropriate stimulation of phagocyte oxy radical production by immune complexes, complement, and other inflammatory mediators may also contribute to the tissue damage and abnormal immune function seen in immune complex disease such as rheumatoid arthritis.5 Congenital deficiency of the NADPHoxidase or abnormalities of its activation are associated with a predisposition to severe pyogenic infection, 6 and, interestingly, the X linked carrier state for one form of NADPH-oxidase deficiency is associated with 'autoimmune-like' phenomena. 7 The role and function of the NADPH-oxidase in microbicidal mechanisms and the genetic basis for defects in this system have been well reviewed.68
In view of the increasing interest in the role of phagocyte oxy radical production in the pathogenesis of disease5 and in the effect of drugs on this function4 this review will examine some of the Accepted for publication 27 October 1986. Correspondence to Dr Nigel P Hurst, The Queen Elizabeth Hospital, Woodville, South Australia 5011. molecular mechanisms which may lead to activation of the NADPH-oxidase in phagocytes.
Metabolic pathways leading to phagocyte superoxide anion release A variety of soluble and particulate agents are capable of activating phagocytes and triggering a respiratory burst', which is characterised by increased oxygen consumption, increased anaerobic glycolysis, and the generation of superoxide and other oxy radicals (Fig. 1) . These events are associated with aVtivation of a membrane NADPHoxidase, which reduces molecular oxygen to superoxide by electron transfer from NADPH.' 8 Agents which activate phagocytes can be further divided into those which act through specific surface membrane receptors and those which act at metabolic sites within the cell. The latter group includes a number of 'artificial' stimuli such as phorbol esters, calcium ionophores, and fluoride ion, whereas the former are mainly physiological agents which are generated during inflammatory reactions (Fig. 1 (Fig. 3) . The role of these IP3 dependent events in the phagocyte respiratory burst, however, remains to be investigated more fully. Diacylglycerol, the other molecule released by inositol lipid hydrolysis, binds and activates the Ca++/phospholipid dependent protein kinase C (PKC).22 24 In the resting cell PKC appears to be cytosolic or only loosely associated with the cell membrane, but during activation it becomes tightly bound to the phagocyte cell membrane 226 (Fig. 3) 35 Mechanism of action of calcium ionophore A23187, phorbol esters, and fluoride Agents which have proved invaluable tools for investigating Ca+ +/calmodulin and PKC dependent pathways are the calcium ionophore A23187 and the biologically active phorbol esters. A23187 mimics the action of IP3 by raising cytosol Ca++, whereas the phorbol esters are believed to act as structural analogues of diacylglycerol which, in association with phospholipid, bind and activate PKC (Fig. 3) .2224 36 pathways independent of PKC and leading to activation of NADPH-oxidase is suggested by recent experiments in our laboratory with the myelomonocytic cell line U937. This cell line, after in vitro differentiation with dimethyl sulphoxide, responds with a respiratory burst to both PMA and serum opsonised zymosan. We have identified a subclone which responds to serum opsonised zymosan but fails to respond to stimulation with PMA (Table 1) . These data suggest the existence of a distinct pathway leading to superoxide release which does not involve PKC. Furthermore, macrophages which have been desensitised with phorbol ester, and are refractory to stimulation by phorbol esters, still respond to serum opsonised zymosan.5
Final common pathway leading to activation of NADPH-oxidase The final steps leading to activation of the NADPHoxidase remain unclear but probably involve phosphorylation of a component of the NADPHoxidase. The NADPH-oxidase has been shown to A further important feature of the final activation process is that, at least in PMN, there appear to be two pools of NADPH-oxidase: one membrane bound and one which requires translocation to the cytoplasmic membrane from cytoplasmic specific granules. 5' 52 Regulation of phagocyte respiratory burst by calcium and protein kinase C Synergistic effect of Ca++ on membrane translocation, activation, and proteolysis of protein kinase C It has been shown that A23187 functions synergistically with activators of PKC such as phorbol ester to elicit physiological responses from a wide variety of cells, including neutrophils, lymphocytes, platelets, pancreatic islets, and many other.2' 22 In both human PMN and monocytes, A23187 shortens the initial 'lag time' and increases the initial rate of response to PMA without affecting total superoxide production.52a 53Thus A23187 appears to affect only early activation events. Recent evidence suggests that the basis for this synergism may be that the rise in calcium induced by A23187 facilitates the initial translocation and binding of PKC to the cell membrane, thereby shortening the activation process27 (Fig. 3) . This model is further supported by the observation that pretreatment of leucocytes with A23187 increases the affinity of binding of
[3H]phorbol dibutyrate to its receptor (i.e., PKC).52a 5 The binding of phorbol esters to PKC is dependent on phospholipid,23 and the association of PKC with the plasma membrane would therefore increase the availability of phospholipid and its binding affinity for phorbol ester.
The potential physiological significance of these observations is twofold. Firstly, calcium fluxes generated in response to ligands which stimulate inositol lipid hydrolysis may accelerate the activation of PKC by diacylglycerol. Secondly, they also suggest a possible mechanism whereby a rise in cytoplasmic calcium, stimulated by an initial signal, may 'prime' PMN for responses to second signals. For example, incubation of PMN with low concentrations of A23187 augments their response to FMLP. 55 Other examples include the 'priming' of PMN by various cytokines, including tumour necrosis factor and interferon-gamma, 6 granulocyte/ macrophage colony stimulating factor, or chemotactic factors (FMLP, C5a),58 which results in augmented phagocytic and respiratory burst activity. Mononuclear phagocytes are similarly activated and 'primed' by a wide variety of agents including macrophage colony stimulating factor,59 interferongamma,60 and bacterial products such as lipopolysaccharide.6' Although the mechanism for each of these examples of 'priming' is uncertain, there is increasing evidence that they may be mediated by a rise in cytosol calcium levels.55 6 Calcium also has a role in proteolysis of activated PKC and the generation of a Ca++/phospholipid independent kinase (PKM). Earlier studies showed that activation of platelets by phorbol esters or phospholipase C resulted in the appearance of a cytosolic 50 kD Ca+ /phospholipid independent protein kinase./3 64 
Conclusions
A more complete picture of the metabolic pathways controlling activation of the phagocyte respiratory burst is beginning to emerge and much of this new information will be relevant to other aspects of phagocyte function. A similar picture is emerging from studies of transmembrane signalling in other types of leucocyte. Although the picture is still incomplete, it should now be possible to apply this new knowledge to studies of the mechanism of action of anti-inflammatory drugs and to the study of phagocyte activation during inflammatory disease. 
